Further research is needed to elucidate the pharmacokinetics of H
They share the same receptor pathway, and doubling up dramatically increases the risk of severe gastrointestinal side effects without proportional benefit
A partir de nuestros estudios globales en salud, consumo y tendencias sociales, observamos que los GLP-1 representan mucho ms que un avance farmacutico: son el detonador de un fenmeno de efecto cascada, donde una innovacin mdica modifica comportamientos humanos, patrones de consumo y modelos de negocio a escala sistmica
Drug metabolism Pharmacokinet
The liver is the most important detoxification organs, which contains rich in glutathione (GSH) on the liver function such as synthesis, detoxification, estrogen inactivated protection.It is the first anti-oxidant that the human body is to counteract the damage of free radicals, and the free radical is a contributing factor to the aging and disease.When the liver is damage, such as suffering from all kinds of liver disease, the body will consume large amounts of GSH to help repair the injured liver and detoxification, that cause the body's glutathione are greatly reduced.But this time we need to take some glutathione peptide drugs, is advantageous to the injury of liver to repair itself.Thus, glutathione peptide drugs are suitable for viral hepatitis (hepatitis a and hepatitis b, etc.), alcoholic liver disease,drug-induced liver disease, fatty liver disease ,its a good medicine to protect liver
